India to France: Furosemide Export Trade Route

The India to France Furosemide corridor is one of India's established pharmaceutical export routes, with 156 shipments documented worth a combined $4.3M USD. The route is dominated by MYLAN LABORATORIES LIMITED, which alone accounts for roughly 51% of all export value, reflecting the consolidated nature of India's furosemide manufacturing sector.

Across 10 active suppliers, the average shipment value stands at $27.9K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 70% of all shipments, consistent with furosemide's non-urgent bulk-order profile.

Shipment activity peaks during January–March, with an average transit time of 26 days port-to-port. The route has recorded an annual growth rate of 10.7%, placing it at rank #3 among India's top furosemide export destinations globally.

On the import side, key buyers of Indian furosemide in France include VIATRIS SANTE, ARROW GENERIQUES,, ARROW GENERIQUES and 14 others. VIATRIS SANTE is the single largest importer with 31 shipments valued at $1.5M USD.

India's furosemide exports to France are driven primarily by a handful of large-scale manufacturers. MYLAN LABORATORIES LIMITED with 56 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 10 active exporters signals a competitive but concentrated market — buyers in France benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — MYLAN LABORATORIES LIMITED, AUROBINDO PHARMA LTD, AUROBINDO PHARMA LIMITED — together account for 83% of total trade value on this route. The average shipment value of $27.9K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as furosemide tablets 40mg(furosemide arrow and furosemide tablets 40 mg , suggesting that buyers in France tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, VIATRIS SANTE is the largest importer with 31 shipments worth $1.5M USD — representing 34% of all furosemide imports from India on this route. A total of 17 buyers are active on this corridor.